SORILUX
Drug
Mayne Pharma Inc.
Total Payments
$356,083
Transactions
361
Doctors
113
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $57,251 | 3 | 1 |
| 2020 | $64,997 | 326 | 111 |
| 2019 | $2,447 | 2 | 2 |
| 2018 | $200,425 | 22 | 0 |
| 2017 | $30,963 | 8 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $288,479 | 32 | 81.0% |
| Consulting Fee | $35,403 | 2 | 9.9% |
| Honoraria | $28,118 | 29 | 7.9% |
| Food and Beverage | $4,083 | 298 | 1.1% |
Payments by Type
Research
$288,479
32 transactions
General
$67,604
329 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| SORILUX PEDIATRIC | Mayne Pharma Inc. | $128,191 | 0 |
| SORILUX5FUCRYO COMBINATION THERAPY | Mayne Pharma Inc. | $65,000 | 0 |
| A multicenter, open-label, Phase 1 study of the safety, tolerability, systemic exposure, pharmacodynamics, and treatment effect of calcipotriene foam, 0.005 in pediatric subjects ages 2 to 11 years with plaque psoriasis | Mayne Pharma Inc. | $29,963 | 0 |
| SORILUX ADOLESCENT | Mayne Pharma Inc. | $7,235 | 0 |
| A Phase 1, Open-Label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Calcipotriene Foam, 0.005, Applied Under Maximal-Use Conditions in Adolescent subjects Ages 12 to 16 Years with Plaque Psoriasis | Mayne Pharma Inc. | $1,000 | 0 |
Top Doctors Receiving Payments for SORILUX
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Dallas, TX | $288,479 | 32 |
| , MD | Dermatology | Lousiville, KY | $35,403 | 2 |
| , DO | MOHS-Micrographic Surgery | Las Vegas, NV | $5,625 | 3 |
| , M.D | Dermatology | New Orleans, LA | $4,343 | 18 |
| , M.D | Dermatology | Smithtown, NY | $2,900 | 4 |
| , MD | Dermatology | Dallas, TX | $2,760 | 3 |
| , MD | Dermatology | Warren, MI | $2,420 | 2 |
| , M.D, | Dermatology | Philadelphia, PA | $1,815 | 2 |
| , MD | Dermatology | Austin, TX | $1,300 | 6 |
| , MD, PHD | Dermatology | Marlborough, MA | $1,250 | 7 |
| , M.D | Specialist | Houston, TX | $1,250 | 2 |
| , M.D | Dermatology | Knoxville, TN | $1,200 | 1 |
| , DO | Dermatology | Fort Lauderdale, FL | $1,200 | 1 |
| , D.O | Dermatology | Newport Beach, CA | $1,200 | 1 |
| , M.D | Dermatology | Birmingham, AL | $937.50 | 1 |
| , M.D | Dermatology | Houma, LA | $218.83 | 18 |
| , M.D | MOHS-Micrographic Surgery | Houma, LA | $203.46 | 18 |
| , M.D | Dermatology | New Orleans, LA | $163.19 | 14 |
| , PA-C | Physician Assistant | Irvine, CA | $160.00 | 1 |
| , M.D | Procedural Dermatology | Metairie, LA | $155.32 | 11 |
| , M.D | Dermatology | Houma, LA | $140.96 | 9 |
| Robert Tausend | — | Pasadena, TX | $122.00 | 9 |
| , M.D | Dermatology | Slidell, LA | $118.12 | 14 |
| , MD | Dermatology | Galveston, TX | $108.75 | 8 |
| , MD | Dermatology | Houston, TX | $99.66 | 7 |
Ad
Manufacturing Companies
- Mayne Pharma Inc. $233,835
- MAYNE PHARMA INC. $122,248
Product Information
- Type Drug
- Total Payments $356,083
- Total Doctors 113
- Transactions 361
About SORILUX
SORILUX is a drug associated with $356,083 in payments to 113 healthcare providers, recorded across 361 transactions in the CMS Open Payments database. The primary manufacturer is Mayne Pharma Inc..
Payment data is available from 2017 to 2021. In 2021, $57,251 was paid across 3 transactions to 1 doctors.
The most common payment nature for SORILUX is "Unspecified" ($288,479, 81.0% of total).
SORILUX is associated with 5 research studies, including "SORILUX PEDIATRIC" ($128,191).